Pharmaceutical Development Corporation presenting at Biofinance 2007

    OAKVILLE, ON, April 20 /CNW/ - Pharmaceutical Development Corporation
( today announced that Diane Kalina, Co-founder and
President, will be presenting at Biofinance 2007 in Toronto. Ms. Kalina's
presentation will take place on Thursday, April 26th at 10:30 am at the
Toronto Marriott Eaton Centre.

    About Pharmaceutical Development Corporation

    Pharmaceutical Development Corporation (PDC) is a private Canadian
biopharmaceutical development company which in-licenses, develops and obtains
financing/partnerships for early stage opportunities in areas of unmet medical
need and for therapeutic areas in which PDC possesses in-house clinical
development expertise. Initially, the company is focusing on the women's
health areas of preterm labour and primary dysmenorrhea.
    PDC's lead molecule, PDC31 (formerly THG113.31) is a peptide which has
shown efficacy in vitro and in animal models of preterm labour. This peptide
is one of a family of peptides and peptidomimetics in-licensed from
Theratechnologies. PDC plans to develop an injectable formulation of PDC31 as
a treatment for acute treatment of pregnant women with preterm labour, and a
topical formulation of the same peptide for use in women with primary

For further information:

For further information: Diane Kalina, President, (905) 829-9770 ext
223; Patricia Griffin, Executive Vice President, (416) 698-0011

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890